2. Asia Pacific: The Preimplantation Genetic Testing market in Asia Pacific, including countries like China, Japan, and South Korea, is expected to experience rapid growth due to the increasing prevalence of genetic disorders, rising healthcare expenditure, and growing demand for advanced genetic testing technologies in the region.
3. Europe: The Preimplantation Genetic Testing market in Europe, specifically in the United Kingdom, Germany, and France, is anticipated to witness steady growth owing to the presence of well-established healthcare systems, supportive government initiatives, and increasing focus on precision medicine and personalized healthcare in the region.